All News

Kidney Cancer Expert Shares Insight on New Therapies

April 1st 2009

New therapies are making headway in a difficult-to-treat cancer.

Meeting Tackles Topics for Young Breast Cancer Survivors

March 20th 2009

The 8th Annual Conference for Young Women Affected by Breast Cancer welcomed women diagnosed with breast cancer at 40 or younger.

Blood Cancers Meeting Stresses the Importance of Clinical Trials

March 6th 2009

Clinical trials and other relevant topics were highlighted at the 2009 Texas Forum on Blood Cancers.

Job Hunting

February 27th 2009

Advice for survivors on looking for employment 

Young Adults Gather to Battle Cancer

December 24th 2008

Young adult cancer survivors raise awareness and resources.

Studies Offer Insight Into Breast Cancer Risk and Mortality for Former HRT Users

December 14th 2008

A brief from this year's San Antonio Breast Cancer Symposium that discusses several new studies that examine the use of hormone replacement therapies and their effects on breast cancer risk and mortality.

New Agents Effectively Target HER2-Positive Cancers

December 13th 2008

A brief from this year's San Antonio Breast Cancer Symposium discussing what new agents researchers have been testing when treating HER2-positive breast cancer.

Looking for the Optimal Treatment Schedule for Taxanes

December 13th 2008

A discussion about the best schedule for a class of drugs continues at the San Antonio Breast Cancer Symposium.

Advocacy Begins at Home: Riding the Rollercoaster of Metastatic Disease

December 13th 2008

CURE Editor-at-Large, Kathy LaTour, tells the story of metastatic cancer survivor Brenda Hutchinson and her involvment with the HER2 Support Group

Doxil Delays Disease Without Increasing the Risk of Heart Damage

December 13th 2008

A brief from this year's San Antonio Breast Cancer Symposium where research was presented on the benefits that the drug Doxil can provide women who have relapsed after anthracycline treatment.

Factors and Regimens That Could Predict Response to Neoadjuvant Therapy Identified

December 13th 2008

A brief from this year's San Antonio Breast Cancer Symposium discusses new research from eight clinical trials that studied whether or not certain factors help to predict response to neoadjuvant therapy prior to surgery.

Postmastectomy Radiation Recommended To Prevent Recurrence in Certain Early-Stage Cancers

December 13th 2008

A brief from this year's San Antonio Breast Cancer Symposium discussing new data showing that patients who receive radiation after having a mastectomy have a lesser chance of recurrence in certain early-stage cancers.

MRI: Friend or Foe?

December 13th 2008

Advocate Joan Venticinque blogs about patient advocacy.

Talk To Us: How Did SABCS Change You?

December 13th 2008

CURE publisher Susan McClure blogs from a survivor's perspective.

Saving the Best for Last

December 13th 2008

Understanding Metastasis

December 13th 2008

How a better understanding of cancer metastasis is suggesting better treatment approaches.

A Few Good Men

December 13th 2008

Why one family is committed to educating the public about male breast cancer.

Breast Density Reduction Predicts Tamoxifen's Preventive Effect

December 13th 2008

A brief from this year's San Antonio Breast Cancer Symposium discussing IBIS-1, a trial that examines tamoxifen's effectiveness as a breast cancer prevention drug, and how breast density is effected by Tamoxifen.

Oncotype DX predicts recurrence with aromatase inhibitor treatment

December 13th 2008

A brief summarizing significant news from this year's San Antonio Breast Cancer Symposium regarding the TransATAC study's results showing that Oncotype DX may now be available for use in women who have taken aromatase inhibitors.

Zometa May Have Direct Effect on Breast Tumors

December 13th 2008

A brief from this year's San Antonio Breast Cancer Symposium detailing research from the AZURE trial that indicates adding the drug Zometa to chemotherapy before surgery may help to shrink breast tumors by an additional third.

Remembering the People Behind the Data

December 13th 2008

Advocate Joan Venticinque blogs about patient advocacy.

Living Well With Metastatic Breast Cancer

December 13th 2008

CURE publisher Susan McClure blogs from a survivor's perspective.

Questions Emerge On Proper Use of Diagnostic Tools

December 13th 2008

CURE Editor-in-Chief Debu Tripathy, MD, blogs on medical issues from SABCS.

A Winning Combination

December 13th 2008

A combination of two well known breast cancer drugs could prove very successful when treating hormone receptor-positive, HER2-positive metastatic disease.

Full-Time Advocate: Bringing SABCS cutting-edge information back home

December 13th 2008

A look at how two-time breast cancer survivor Joan Venticinque got her start in advocacy and where she thinks the future may take her.

Data Confirms Zometa Reduces Bone Loss and Recurrence Risk

December 13th 2008

A brief discussing findings from this year's San Antonio Breast Cancer Symposium showing that research suggests that the drug Zometa may provide patients with reduced bone loss and a lesser chance of recurrence.

Phase III Trial Planned for RAD001 with Herceptin-Chemo Combo

December 13th 2008

A brief discussing investigation agent RAD001 (everolimus), a drug currently approved to treat kidney cancer, and the findings that now show the drug may be used to treat breast cancer.

Herceptin Before Surgery Highly Effective in Locally Advanced Breast Cancer

December 13th 2008

A brief discussing the data from the NOAH trial in which Herceptin was added to chemotherapy before surgery for HER2-positive locally advanced breast cancer.

Male Breast Cancer: Not Pink and Not Enough Awareness

December 13th 2008

Looking for Answers to Recurrence Years After Surgery

December 13th 2008

CURE Editor-in-Chief Debu Tripathy, MD, blogs on medical issues from SABCS.